Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR

Biochemical Journal

Volumn 407, Issue 2, 2007, Pages 231-241

  Geraghty, Kathryn M ^a   Chen, Shuai ^a   Harthill, Jean E ^a   Ibrahim, Adel F ^a   Toth, Rachel ^a   Morrice, Nick A ^a   Vandermoere, Franck ^a   Moorhead, Greg B ^b   Hardie, D Grahame ^a   MacKintosh, Carol ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

14 3 3; Akt substrate of 160 kDa (AS160); Akt protein kinase B (PKB); GTPase activating protein (GAP); p90 ribosomal S6 kinase (RSK); Serum and glucocorticoid induced protein kinase (SGK)

Indexed keywords

AKT SUBSTRATE OF 160 KDA (AS160); AKT/PROTEIN KINASE B (PKB); GTPASE-ACTIVATING PROTEIN (GAP); P90 RIBOSOMAL S6 KINASE (RSK); SERUM- AND GLUCOCORTICOID-INDUCED PROTEIN KINASE (SGK);

AFFINITY CHROMATOGRAPHY; BINDING SITES; GENE EXPRESSION; GROWTH KINETICS; PHOSPHORYLATION; TISSUE;

ENZYMES;

5 AMINO 4 IMIDAZOLECARBOXAMIDE 1 BETA DEXTRO RIBOFURANOSIDE; ALANINE; AMIDE; AS160 PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN KINASE C; S6 KINASE; SERINE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SOMATOMEDIN C; THREONINE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ARTICLE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

14-3-3 PROTEINS; AMINO ACIDS; AMINOIMIDAZOLE CARBOXAMIDE; BINDING SITES; CELL LINE; EPIDERMAL GROWTH FACTOR; GTPASE-ACTIVATING PROTEINS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PHOSPHORYLATION; PROTEIN BINDING; RIBONUCLEOTIDES;

TOSCANA VIRUS;

EID: 35048903018     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070649     Document Type: Article

References (49)

1. MacKintosh, C. (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381, 329-342
2. Benzinger, A., Muster, N., Koch, H. B., Yates, 3rd, J. R. and Hermeking, H. (2005) Targeted proteomic analysis of 14-3-3σ, a p53 effector commonly silenced in cancer. Mol. Cell. Proteomics 4, 785-795
3. Jin, J., Smith, F. D., Stark, C., Wells, C. D., Fawcett, J. P., Kulkarni, S., Metalnikov, P., O'Donnell, P., Taylor, P., Taylor, L. et al. (2004) Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 14, 1436-1450
4. Meek, S. E., Lane, W. S. and Piwnica-Worms, H. (2004) Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J. Biol. Chem. 279, 32046-32054
5. Pozuelo Rubio, M., Geraghty, K. M., Wong, B. H., Wood, N. T., Campbell, D. G., Morrice, N. and Mackintosh, C. (2004) 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem. J. 379, 395-408
6. Harthill, J. E., Pozuelo Rubio, M., Milne, F. C. and MacKintosh, C. (2002) Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells. Biochem. J. 368, 565-572
7. Pozuelo Rubio, M., Peggie, M., Wong, B. H., Morrice, N. and MacKintosh, C. (2003) 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. EMBO J. 22, 3514-3523
8. Cai, S. L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K. and Walker, C. L. (2006) Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 173, 279-289
9. Li, Y., Inoki, K., Yeung, R. and Guan, K. L. (2002) Regulation of TSC2 by 14-3-3 binding. J. Biol. Chem. 277, 44593-44596
10. Kip1. EMBO J. 23, 1934-1942
11. Rena, G., Prescott, A. R., Guo, S., Cohen, P. and Unterman, T. G. (2001) Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem. J. 354, 605-612
12. Howlett, K. F., Sakamoto, K., Garnham, A., Cameron-Smith, D. and Hargreaves, M. (2007) Resistance exercise and insulin regulate AS160 and interaction with 14-3-3 in human skeletal muscle. Diabetes 56, 1608-1614
13. Ramm, G., Larance, M., Guilhaus, M. and James, D. E. (2006) A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160. J. Biol. Chem. 281, 29174-29180
14. Kane, S., Sano, H., Liu, S. C., Asara, J. M., Lane, W. S., Garner, C. C. and Lienhard, G. E. (2002) A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 277, 22115-22118
15. Perseghin, G., Petersen, K. and Shulman, G. I. (2003) Cellular mechanism of insulin resistance: potential links with inflammation Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3), S6-S11
16. Ishikura, S., Bilan, P. J. and Klip, A. (2007) Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells. Biochem. Biophys. Res. Commun. 353, 1074-1079
17. Larance, M., Ramm, G., Stockli, J., van Dam, E. M., Winata, S., Wasinger, V., Simpson, F., Graham, M., Junutula, J. R., Guilhaus, M. and James, D. E. (2005) Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J. Biol. Chem. 280, 37803-37813
18. Miinea, C. P., Sano, H., Kane, S., Sano, E., Fukuda, M., Peranen, J., Lane, W. S. and Lienhard, G. E. (2005) AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem. J. 391, 87-93
19. Sano, H., Eguez, L., Teruel, M. N., Fukuda, M., Chuang, T. D., Chavez, J. A., Lienhard, G. E. and McGraw, T. E. (2007) Rab10, a target of the AS160 Rab GAP, is reguired for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab. 5, 293-303
20. Karlsson, H. K., Zierath, J. R., Kane, S., Krook, A., Lienhard, G. E. and Wallberg-Henriksson, H. (2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54, 1692-1697
21. Watson, R. T. and Pessin, J. E. (2006) Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem. Sci. 31, 215-222
22. Sano, H., Kane, S., Sano, E., Miinea, C. P., Asara, J. M., Lane, W. S., Garner, C. W. and Lienhard, G. E. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599-14602
23. Peck, G. R., Ye, S., Pham, V., Fernando, R. N., Macaulay, S. L., Chai, S. Y. and Albiston, A. L. (2006) Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol. Endocrinol. 20, 2576-2583
24. Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S. et al. (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081
25. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M. and Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646
26. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
27. Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F. and Goodyear, L. J. (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067-2076
28. Thong, F. S., Bilan, P. J. and Klip, A. (2007) The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 56, 414-423
29. Bruss, M. D., Arias, E. B., Lienhard, G. E. and Cartee, G. D. (2005) Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54, 41-50
30. Treebak, J. T., Glund, S., Deshmukh, A., Klein, D. K., Long, Y. C., Jensen, T. E., Jorgensen, S. B., Viollet, B., Andersson, L., Neumann, D. et al. (2006) AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55, 2051-2058
31. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175
32. 433, is essential for LKB1 to suppress cell growth. J. Biol. Chem. 276, 19469-19482
33. Williamson, B. L., Marchese, J. and Morrice, N. A. (2006) Automated identification and quantification of protein phosphorylation sites by LC/MS on a hybrid triple quadrupole linear ion trap mass spectrometer. Mol. Cell. Proteomics 5, 337-346
34. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., Frodin, M., Grauert, M., Hoffmann, M., Schnapp, G., Steegmaier, M., Cohen, P. and Alessi, D. R. (2007) BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38
35. Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H. J. and Johannes, F. J. (1996) Inhibition of protein kinase Cμ by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 77-80
36. Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K., Hara, K., Tanaka, N., Avruch, J. and Yonezawa, K. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278, 15461-15464
37. Saitoh, M., Pullen, N., Brennan, P., Cantrell, D., Dennis, P. B. and Thomas, G. (2002) Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem. 277, 20104-20112
38. Schalm, S. S. and Blenis, J. (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639
39. Hardie, D. G., Hawley, S. A. and Scott, J. W. (2006) AMP-activated protein kinase: development of the energy sensor concept. J. Physiol. 574, 7-15
40. Marsin, A. S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., Van den Berghe, G., Carling, D. and Hue, L. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247-1255
41. Nakano, M., Hamada, T., Hayashi, T., Yonemitsu, S., Miyamoto, L., Toyoda, T., Tanaka, S., Masuzaki, H., Ebihara, K., Ogawa, Y. et al. (2006) α2 Isoform-specific activation of 5′adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. Metabolism 55, 300-308
42. Karlsson, H. K., Hallsten, K., Bjornholm, M., Tsuchida, H., Chibalin, A. V., Virtanen, K. A., Heinonen, O. J., Lonnqvist, F., Nuutila, P. and Zierath, J. R. (2005) Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. Diabetes 54, 1459-1467
43. Knebel, A., Morrice, N. and Cohen, P. (2001) A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38δ. EMBO J. 20, 4360-4369
44. Sarbassov dos, D., Ali, S. M. and Sabatini, D. M. (2005) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603
45. Corradetti, M. N., Inoki, K., Bardeesy, N., DePinho, R. A. and Guan, K. L. (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533-1538
46. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590
47. Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A. and Cantley, L. C. (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91-99
48. Stone, S., Abkevich, V., Russell, D. L., Riley, R., Timms, K., Tran, T., Trem, D., Frank, D., Jammulapati, S., Neff, C. D. et al. (2006) TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum. Mol. Genet. 15, 2709-2720
49. Roach, W. G., Chavez, J. A., Miinea, C. P. and Lienhard, G. E. (2007) Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein TBC1D1. Biochem. J. 403, 353-358